Project Grant HT94252510970
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $467K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The U.S. Defense Health Agency has awarded a $2,028,000.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. The grant, awarded on April 1, 2025, supports research to identify epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. As a leading academic medical research institution, ISMMS has demonstrated extensive capabilities in conducting...
- This federal Project Grant award of $507,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate tumor-intrinsic epigenetic mechanisms that modulate antitumor immune responses in metastatic prostate cancer. The award was made to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research institution located in New York, NY. This grant aims to advance the...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the Icahn School of Medicine at Mount Sinai in New York, NY to investigate the impact of the PIK3R1-insulin-glucose metabolism pathway in lethal prostate cancer with the goal of developing new therapeutic strategies. The $505,270 award, granted on Sep 30, 2025, will fund this research project over a 2-year period through Sep 29, 2027. As a...
- This $507,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the Icahn School of Medicine at Mount Sinai (ISMMS) to study the role of exosomes in promoting prostate cancer metastasis and resistance to androgen deprivation therapy. The 2-year grant, awarded on June 15, 2024, will enable ISMMS to conduct innovative biomedical research with the goal of advancing understanding and treatment of...
- The Icahn School of Medicine at Mount Sinai will receive $1,420,835 under a three-year Project Grant from the Defense Health Agency to target the immunosuppressive microenvironment of prostate cancer and enhance the therapeutic efficacy of immune checkpoint inhibitors. The grant, awarded June 1, 2023 under the Military Medical Research and Development program (CFDA 12.420), will support basic, applied, and advanced biomedical research aimed at transforming health care for service members and the...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,227,478.00 Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development program (CFDA 12.420) to support research on developing biomarkers for an individualized, risk-adapted approach to bladder-sparing treatment for muscle-invasive bladder cancer. This research project will run from July 1, 2025, to June 30, 2028, and aims to transform healthcare for military service members...
- This federal Project Grant award of $202,800 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. The award is focused on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis" and will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award...
- The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
- This $1,029,002 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Arizona Veterans Research And Education Foundation to identify recessive prostate cancer risk alleles in the Million Veterans Program. The project aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research focused on prostate cancer. The award term is from September...
- The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...